Literature DB >> 4595320

Immunotherapy of melanoma with intralesional BCG.

R S Bornstein, M J Mastrangelo, H Sulit, D Chee, J W Yarbro, L M Prehn, R T Prehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4595320

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  4 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

3.  Methanol extraction residue of BCG in the treatment of transplanted rat tumours.

Authors:  D G Hopper; M V Pimm; R W Baldwin
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

4.  Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer.

Authors:  Paul Toomey; Krithika Kodumudi; Amy Weber; Lisa Kuhn; Ellen Moore; Amod A Sarnaik; Shari Pilon-Thomas
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.